An analysis of the most pressing concerns based on insights from 1,000 UK business leaders.
There have been many technical changes over the past decade in the life sciences sector, these include the advent of AI or wearable tech. There has also been the increase in digital interactions between life science companies, their supply chain and partners. The pace of these changes increased further with the COVID-19 pandemic, making home working and remote clinical trials, the new norms.
However, this fast-paced progress has also resulted in life sciences companies experiencing major negative side-effects, in the form of increased cyber threats.
Our guide highlights the evolving cyber threats that life science companies can face and it explains the steps they can take, to increase their resilience to these ever evolving threats.